Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,378 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Recruiting

Mosaic Trial for Stem Cell Transplant Recipients

NCT06960993

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Bone Marrow Transplant, +22 more
Locations
  • Georgetown University School of Medicine Washington D.C., District of Columbia, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Hackensack Meridian Health Nutley, New Jersey, United States
View Trial Details
Recruiting

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

NCT06287944

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations
  • City of Hope Medical Center Duarte, California, United States
View Trial Details
Recruiting

Personalized NK Cell Therapy in CBT

NCT02727803

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT07020533

Conditions
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +38 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

NCT07155226

Conditions
Acute Lymphoblastic Leukaemia, Acute Myeloid Leukaemia, Bone Marrow Diseases, +15 more
Locations
  • Research Site Decatur, Illinois, United States
  • Research Site New York, United States
  • Research Site Chapel Hill, North Carolina, United States
  • Research Site Durham, North Carolina, United States
View all 30 locations
View Trial Details

Related conditions